May 21, 2019

Ganja liqui-gel medication closer to production

The medical sciences research company, MMJ International Holdings, based in the United States and Jamaica, has reached an agreement with Thermo Fisher Scientific to manufacture its […]
May 14, 2019

MMJ International Holdings Following FDA Guidance in Cannabis Drug Development Process

ST. PETERSBURG, FL / ACCESSWIRE / May 10, 2019 / MMJ International Holdings, the premier medical cannabis research company, recently announced that the FDA has made […]
May 3, 2019

Hall Of Flowers: Acquisitions And Celebrity Cannabis Debuts

Curaleaf is Acquiring Select Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”), a vertically integrated cannabis operator in the United States, announced today it has signed […]
November 14, 2018

MMJ International Holdings Files FDA Orphan Drug Application for Huntington’s Disease

MMJ International Holdings, the premier medical cannabis research company, announced that is has filed an application with the FDA for “Orphan Drug Designation” for its drug […]
December 12, 2017

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment MMJ International Holding’s, the premier medical cannabis research company that is advancing the science […]
November 27, 2017

MMJ International Holdings Announces US Patent Filing for Multiple Sclerosis Cannabinoid Treatment

MMJ International Holdings, the premier medical cannabis research company that is advancing the science of medical marijuana through patient clinical research and the operation of medical […]
November 13, 2017

MMJ BioScience Proceeding with FDA Multiple Sclerosis Clinical Trial of Medicinal Cannabis 2018

The MMJ BioScience team will be carefully conducting these controlled clinical studies to determine the benefits and risks of medical marijuana products for safe patient use. […]